Geniposide attenuates spermatogenic dysfunction via inhibiting endoplasmic reticulum stress in male mice

Yan-Nan Chi,Rui-Juan Ye,Jia-Mei Yang,Dong-Mei Hai,Ning Liu,Jia-Wei Ren,Juan Du,Xiao-Bing Lan,Jian-Qiang Yu,Lin Ma
DOI: https://doi.org/10.1016/j.cbi.2022.110144
2022-10-01
Abstract:BackgroundSpermatogenesis dysfunction is common in clinically infertile patients. Geniposide (GP) is one of the important active ingredients extracted from Eucommia ulmoides. However, the protective effect and mechanism of GP in the treatment of spermatogenic dysfunction is not known yet.MethodsAfter cyclophosphamide-induced spermatogenic dysfunction was established in male mice, we gavaged GP for 4 weeks to evaluate spermatogenic function and anti-apoptotic effects by fertility, testicular weight, sperm quality, endoplasmic reticulum stress (ER stress), comet assay and serum testosterone level.ResultsGP can improve the damage of fertility and reproductive organs induced by cyclophosphamide and increase the number and activity of sperm. In comet assay, it was found that GP administration could alleviate sperm DNA damage induced by cyclophosphamide. In addition, GP treatment can significantly reduce ThT fluorescence intensity and improve endoplasmic reticulum stress induced by cyclophosphamide. Besides, TUNEL staining and WB showed that GP could inhibit the excessive apoptosis of cells and protect testis. (p < 0.05, p < 0.01, p < 0.001).ConclusionThe protective effect of Geniposide on cyclophosphamide-induced spermatogenic dysfunction in mice is related to the inhibition of endoplasmic reticulum stress.
pharmacology & pharmacy,biochemistry & molecular biology,toxicology
What problem does this paper attempt to address?